(Total Views: 490)
Posted On: 02/24/2022 10:11:49 PM
Post# of 145900
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Trying to form a realistic expectation of what might happen in the next week to month or two - and based on what I know (and I'm not nearly as up to speed as frequent posters), - i''m going to guess that our first PR will announce excellent 700 mg NASH results - and they were so good, that we now have a BP partner to help get Leronlimab approved/marketed for liver disease.
So, if that's the case, does anyone have a guess on what that would do to the SP in the following days? From what I know, there's not a lot of options for patients with liver disease; is that true?
In short, what's a best guess on SP reaction if we have great 700 mg results and partner up for NASH?
So, if that's the case, does anyone have a guess on what that would do to the SP in the following days? From what I know, there's not a lot of options for patients with liver disease; is that true?
In short, what's a best guess on SP reaction if we have great 700 mg results and partner up for NASH?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)